Patients with newly diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL) research hub

International prospective Phase 2 trial addressing the efficacy of first-line Chlamydophila psittaci-eradicating therapy with protracted administration of doxycycline followed by eradication monitoring and antibiotic re-treatment at infection re-occurrence in patients with newly diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL)

This study looks at treating a specific type of eye cancer called OAMZL with doxycycline, an antibiotic. It aims to see how well this treatment prevents the cancer from growing or coming back over two years.